See also this year's filing and all EDGAR filings for this company.
PDF Report 0001597553_2020_Sage_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001597553, Sage Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,035,093,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 9,126,000 |
| 3 | remainder_Assets | 39,931,000 |
| 4 | LiabilitiesCurrent | 112,128,000 |
| 5 | LiabilitiesNoncurrent | 27,367,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 345,777,000 |
| 9 | ResearchAndDevelopmentExpense | 368,815,000 |
| 10 | remainder_Expenses | 400,000 |
| 11 | remainder_Revenues | 6,868,000 |
| 12 | remainder_NetIncome | 27,886,000 |
| 13 | remainder_ComprehensiveNetIncome | 1,810,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,084,150,000 |
| 1 | Liabilities | 139,495,000 |
| 2 | Expenses | 714,992,000 |
| 3 | Revenues | 6,868,000 |
| 4 | StockholdersEquity | 944,655,000 |
| 5 | NetIncome | -680,238,000 |
| 6 | ComprehensiveNetIncome | -679,333,000 |
| 7 | BaseVar | 987,600,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.26 |
| 9 | EconomicCapitalRatio | 3.19 |